HomeNews Mattress Firm, Protect-A-Bed Team Up To Fight Pancreatic Cancer

Mattress Firm, Protect-A-Bed Team Up To Fight Pancreatic Cancer

A portion of November mattress protector sales goes to cancer research.

|
October 27, 2010

HOUSTON – Mattress Firm and Protect-A-Bed are joining forces to raise money to support the Pancreatic Cancer Action Network (PanCan) and the Translational Genomics Research Institute (TGen). During the month of November, National Pancreatic Cancer Awareness Month, a portion of the proceeds from all Protect-A-Bed product sales at any Mattress Firm location will go directly to PanCan and TGen to further fund research to save lives.

This year, Mattress Firm is also providing the opportunity for the general public to make a donation online at http://www.firstgiving.com/mattfirmandpab. All funds raised go directly to PanCan, which is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those affected by pancreatic cancer (www.pancan.org).

“At Mattress Firm, we support the communities that we live and work in. Pancreatic cancer has no boundaries and so we are proud to partner with Protect-a-Bed for company-wide effort to do our part to help find a cure,” said Karrie Forbes, Mattress Firm vice president of marketing. “Pancreatic cancer takes far too many lives every year, and we hope that our contributions can aid in the effort for medical breakthroughs in early detection, sustainable treatment and a cure.”

A similar sentiment is expressed by the executive team at Protect-A-Bed, "Protect-A-Bed has been a long-time supporter of pancreatic cancer research," said James Bell, CEO of Protect-A-Bed. "By joining forces with Mattress Firm, PanCan and TGen for this special in-store promotion, I am confident we will help researchers get one step closer to finding a cure for one of the nation's deadliest forms of cancer."

Every penny counts, as pancreatic cancer is the fourth leading cause of cancer related deaths in the United States and has the highest mortality rate of any of the major cancers with only 5% of those affected surviving longer than five years. New cases continue to rise and it’s estimated that 43,140 men and women will be diagnosed with Pancreatic Cancer and 36,800 will die of it this year alone.

The company said its fourth-quarter earnings rose 17%. Ecolab CEO Doug Baker said the company’s U.S. pest business “has been steadily improving” due to a number of investments in that business starting two years ago.